Xenetic Biosciences to merge with Santersus in all-stock deal
Xenetic Biosciences agreed to combine with privately held therapeutic medical-device company Santersus in an all-stock reverse merger. Xenetic said Santersus investors would own about 85% of the combined company, while current Xenetic shareholders would own roughly…
Xenetic Biosciences has agreed to combine with privately held therapeutic medical-device company Santersus in an all-stock reverse merger. Xenetic said on Wednesday that Santersus investors would own about 85% of the combined company, while current Xenetic shareholders would own roughly the remainder.